Characterization of novel FcεRII/CD23 isoforms lacking the transmembrane (TM) segment in human cell lines

Molecular Immunology

Volumn 36, Issue 18, 1999, Pages 1223-1233

  Yoshikawa, Tsutomu ^a,b   Matsui, Minoru ^a,c   Gon, Yasuhiro ^a,d   Yoshioka, Tatsuki ^a   Hirama, Minoru ^b   Lynch, Richard G ^e   Naito, Koji ^b   Yodoi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Drug Discovery Institute   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NIHON UNIVERSITY   (Japan)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; IMMUNOGLOBULIN E RECEPTOR; ISOPROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT; PRIMER DNA; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL LINE; CELL STRAIN COS1; CELL SURFACE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; IN VITRO STUDY; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BASE SEQUENCE; CELL LINE; COS CELLS; DNA PRIMERS; GLYCOSYLATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; RABBITS; RECEPTORS, IGE; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFECTION;

EID: 0033233387     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00139-X     Document Type: Article

References (53)

1. Armant M., Ishihara H., Rubio M., Delespesse G., Sarfati M. Regulation of cytokine Production by soluble CD23: Costimulation of interferon γ secretion and triggering of tumor necrosis factor α release. J. Exp. Med. 180:1994;1005-1011.
2. Armant M., Rubio M., Delespesse G., Sarfati M. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J. Immunol. 155:1995;4868-4875.
3. Aubry J.P., Pochon S., Graber P., Jansen K.U., Bonnefoy J.-Y. CD21 is a ligand for CD23 and regulates IgE production. Nature. 358:1992;505-507.
4. Bocek P.J., Guthmann M.D., Pecht I. Analysis of the genes encoding the mast cell function-associated antigen and its alternative spliced transcripts. J. Immunol. 158:1997;3235-3243.
5. Bonnefoy J.-Y., Plater-Zyberk C., Lecoanet-Henchoz S., Gauchat J.-F., Aubry J.-P., Graber P. A new role for CD23 in inflammation. Immunol Today. 17:1996;418-420.
6. Capron A., Dessaint J.P., Capron M., Joseph M., Ameisen J.C., Tonnel A.B. From parasites to allergy: a second receptor for IgE. Immunol. Today. 7:1986;15-18.
7. Coligan J.E., Gates F.T. III, Kimball E.S., Maloy W.L. Radiochemical sequence analysis of biosynthetically labeled proteins. Methods Enzymol. 91:1983;413-434.
8. Flores-Romo L., Shields J., Humbert Y., Graber P., Aubry J.P., Gauchat J.F., et al. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science. 261:1993;1038-1041.
9. Gonzalez-Molina A., Spiegelberg H.L. A subpopulation of normal human peripheral B lymphocytes that bind IgE. J. Clin. Invest. 59:1977;616-624.
10. Gordon J. B-cell signalling via the C-type lectins CD23 and CD72. Immunol. Today. 15:1994;411-417.
11. Guthmann M.D., Tal M., Pecht I. A secretion inhibitory signal transduction molecule on mast cells in another C-type lectin. Proc. Natl. Acad. Sci. USA. 92:1995;9397-9401.
12. Huff T.F., Yodoi J., Ueda T., Ishizaka K. Presence of an antigenic determinant common to rat IgE-potentiating factor, IgE-suppressive factor, and Fcε receptors on T and B lymphocytes. J. Immunol. 132:1984;406-412.
13. Ikizawa K., Yanagihara Y., Kajiwara K., Koshio T., Shida T., Yamada A. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis. Int. Arch. Allergy Immunol. 101:1993;416-424.
14. Ikuta K., Takami M., Kim C.W., Honjo T., Miyoshi T., Tagaya Y., et al. Human lymphocyte Fc receptor for IgE: Sequence homology of its cloned cDNA with animal lectins. Proc. Natl. Acad. Sci. USA. 84:1987;819-823.
15. Kato H., Inamoto T., Nakamura H., Furuke K., Uemoto S., Tanaka K., et al. Soluble CD23 as a sensitive markers after liver transplantation. Transplantation. 56:1993;1109-1113.
16. Kato H., Inamoto T., Uemoto S., Egawa H., Inomata Y., Tanaka K., et al. Diagnosis of Epstein-Barr virus lymphoma after liver transplantation. Gann Monograph Cancer Res. 45:1998;149-153.
17. Kehry M.R., Yamashita L.C. Low-affinity receptor (CD23) function on mouse B cells: Role in IgE-dependent antigen focusing. Proc. Natl. Acad. Sci. USA. 86:1989;7556-7560.
18. Kikutani H., Inui S., Sato R., Barsumian E.L., Owaki H., Yamasaki K., et al. Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell. 47:1986;657-665.
19. Kim K.M., Mayumi M., Iwai Y., Tanaka M., Ito S., Shinomiya K., Mikawa H. IgE receptor-bearing lymphocytes in allergic and nonallergic children. Pediatr. Res. 24:1988;254-257.
20. Kim K.M., Nanbu M., Iwai Y., Tanaka M., Yodoi J., Mayumi M., Mikawa H. Soluble low affinity Fc receptors for IgE in the surum of allergic and nonallergic children. Pediatr. Res. 26:1989;49-53.
21. Kornfield R., Kornfield S. Assembly of asparagine-linked oligosaccharides. Ann. Rev. Biochem. 54:1985;631-664.
22. Lamers M.B., Lamont A.G., Williams D.H. Human MAFA has alternative spliced variants. Biochem. Biophys. Acta. 1399:1998;209-212.
23. Lecoanet-Henchoz S., Gauchat J.-F., Aubry J.-P., Graber P., Life P., Paul-Eugene N., et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity. 3:1995;119-125.
24. Lecoanet-Henchoz S., Plater-Zyberk C., Graber P., Gretener D., Aubry J.-P., Conrad D.H., Bonnefoy J.-Y. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur. J. Imuunol. 27:1997;2290-2294.
25. Letellier M., Nakajima T., Delespesse G. IgE receptor on human lymphocytes. IV. Further analysis of its structure and the role of N-linked carbohydrates. J. Immunol. 141:1988;2374-2381.
26. Letellier M., Sarfati M., Delespesse G. Mechanisms of formation of IgE-binding factors (soluble CD23). I. Fc epsilon R II bearing B cells generate IgE-binding factors of different molecular weights. Mol. Immunol. 26:1989;1105-1112.
27. Letellier M., Nakajima T., Pulido-Cejudo G., Hofstetter H., Delespesse G. Mechanism of formation of human IgE-binding factors (soluble CD23). III. Evidence for a receptor (FcεRII)-associated proteolytic activity. J. Exp. Med. 172:1990;693-700.
28. Liu Y.-J., Cairns J.A., Holder M.J., Abbot S.O., Jansen K.U., Bonnefoy J.-Y., et al. Recombinant 25-kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 21:1991;1107-1114.
29. Lodish H.F. Transport of secretory and membrane glycoproteins from the rough endoplasmic reticulum to the Golgi. A rate-limiting step in protein maturation and secretion. J. Biol. Chem. 263:1988;2107-2110.
30. Ludin C., Hofstetter H., Sarfati M., Levy C.A., Suter U., Alaimo D., et al. Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor. EMBO J. 6:1987;109-114.
31. Matsui M., Nunez R., Sachi Y., Lynch R.G., Yodoi J. Alternative transcripts of the human CD23/FcεRII: A possible mechanism of generating a soluble isoform in the type-II cell surface receptor. FEBS Lett. 335:1993;51-56.
32. Melewics F.M., Plummer J.M., Spiegelberg H.L. Comparison of the Fc receptor for IgE on human lymphocytes and monocytes. J. Immunol. 129:1982;563-569.
33. Mossalayi M.D., Arock M., Bertho J.M., Blanc C., Dalloul A.H., Hofstetter H., et al. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood. 75:1990;1924-1927.
34. Nakabeppu Y., Nathans D. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell. 64:1991;751-759.
35. Neefjes J.J., Ploegh H.L. Intracellular transport of MHC class II molecules. Immunol. Today. 13:1992;179-184.
36. Noro N., Yoshioka A., Adachi M., Yasuda K., Masuda T., Yodoi J. Monoclonal antibody (H107) inhibiting IgE binding to FcεR(+) human lymphocytes. J. Immunol. 137:1986;1258-1263.
37. Nunez R., Lynch R.G. CD23 isoforms in murine T and B lymphocytes. Pathobiology. 61:1993;128-137.
38. Nunez R., Matsui M., Yodoi J., Lynch R.G. Identification of novel CD23 transcripts on human T and B lymphocytes and eosinophil cell line. Immunol. Lett. 44:1995;169-174.
39. Pirron U., Schlunck T., Prinz J.C., Rieber E.P. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur. J. Immunol. 20:1990;1547-1551.
40. Sarfati M., Nutman T., Fonteyn C., Delespesse G. Presence of antigenic determinants common to Fc IgE receptors on human macrophages, T and B lymphocytes and IgE-binding factors. Immunology. 59:1986;569-575.
41. Sarfati M., Delespesse G. Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE. J. Immunol. 141:1988;2195-2199.
42. Sherr E., Macy E., Kimata H., Gilly M., Saxon A. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis. J. Immunol. 142:1989;481-489.
43. Spiegelberk H.L., O'Connor R.D., Simon R.A., Mathison D.A. Lymphocytes with IgE Fc receptors in patients with atopic disorders. J. Clin. Invest. 64:1979;714-720.
44. Suter U., Bastos R., Hofstetter H. Molecular structure of the gene and the 5′-flanking region of the human lymphocyte immunoglobulin E receptor. Nucleic Acids Res. 15:1987;7295-7308.
45. Wang F., Gregory C.D., Rowe M., Rickinson A.B., Wang D., Birkenbach M., et al. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc. Natl. Acad. Sci. USA. 84:1987;3452-3456.
46. Wickner W.T., Lodish H.F. Multiple mechanisms of protein insertion into and across membranes. Science. 230:1985;400-407.
47. Ying H., Nakayama E., Robinson W.H., Parnes J.R. Structure of the mouse CD72 (Lyb-2) gene and its alternatively spliced transcripts. J. Immunol. 154:1995;2743-2752.
48. Yodoi J., Ishizaka K. Lymphocytes bearing Fc receptors for IgE. I. Presence of human and rat T lymphocytes with Fcε receptors. J. Immunol. 122:1979;2577-2583.
49. Yodoi J., Ishizaka K. Lymphocytes bearing Fc receptors for IgE. VI. Formation of IgE-binding factor by rat T lymphocytes. J. Immunol. 124:1980;1322-1329.
50. Yodoi J., Hosoda M., Takami M., Kawabe T. Regulation of the expression of FcεR2 and IgE-BF. Fridman W.H. Chem. Immunol. vol. 47:1989;106-127 Karger, Basel.
51. Yodoi J., Hosoda M., Maeda Y., Sato S., Takami M., Kawabe T. Low affinity IgE receptor: regulation and functional roles in cell activation. Chichester W. Ciba Found. Symp. vol. 147:1989;133-153.
52. Yokota A., Kikutani H., Tanaka T., Sato R., Barsumian E.L., Suemura M., Kishimoto T. Two species of human Fcε receptor II (FcεRII/CD23): Tissue-specific and IL-4-specific regulation of gene expression. Cell. 55:1988;611-618.
53. Yoshikawa T., Nanba T., Kato H., Hori K., Inamoto T., Kumagai S., Yodoi J. Soluble FcεRII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: Analysis by ELISA for soluble FcεRII/CD23. Immunomethods. 4:1994;65-71.